Proglycem

Active Ingredient(s): Diazoxide
FDA Approved: * May 28, 1976
Pharm Company: * BAKER NORTON
Category: Hypoglycemia

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Proglycem Overview

Diazoxide (INN; brand name Proglycem[1]) is a potassium channel activator, which causes local relaxation in smooth muscle by increasing membrane permeability to potassium ions. This switches off voltage-gated calcium ion channels, preventing calcium flux across the sarcolemma and activation of the contractile apparatus. In the United States, this agent is only available in the oral form and is typically given in hospital settings.[2] Contents 1 Medical uses...

Read more Proglycem Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Diazoxide

Recent Proglycem Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Diazoxide
  • Capsule: 100mg, 50mg
  • Injection: 15mg/ml
  • Suspension: 50mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Proglycem: (1 result)

Sorted by National Drug Code
  • 0575-6200 Proglycem 50 mg/ml Oral Suspension by Teva Global Respiratory Research LLC

Other drugs which contain Diazoxide or a similar ingredient: (2 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 17 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA